Killory Brendan D, Kilbourn Kent J, Ollenschleger Martin
Department of Neurosurgery, Hartford Hospital, Hartford, Connecticut, USA.
Department of Neurosurgery, Hartford Hospital, Hartford, Connecticut, USA.
World Neurosurg. 2015 Dec;84(6):2078.e1-4. doi: 10.1016/j.wneu.2015.08.016. Epub 2015 Aug 24.
Dual antiplatelet therapy is associated with increased rates of intracerebral hemorrhage, especially in the context of subarachnoid hemorrhage. We present a case of a spontaneous hemorrhage in a patient treated with a Pipeline stent for a ruptured dissecting vertebrobasilar aneurysm and the novel use of direct application of platelets during surgery to control bleeding.
A 54-year-old previously healthy woman presented with an intradural right vertebral artery dissection with a ruptured 6-mm pseudoaneurysm. The patient was started on aspirin and clopidogrel and the vessel was reconstructed with 2 Pipeline Embolization Devices. On postbleed day number 14, she became obtunded with a blown right pupil; computed tomography of the head demonstrated a large right temporal intracerebral hematoma. The patient was taken emergently to the operating room for evacuation of the clot. Intraoperatively, satisfactory control of bleeding was not achieved despite transfusing several units of platelets intravenously. Ultimately, a mixture of Floseal and platelets applied directly to the hematoma wall allowed prompt hemostasis. At 3 months the patient was doing extremely well clinically and angiography demonstrated occlusion of the aneurysm.
This is the first reported description of direct application of platelets to achieve intraoperative hemostasis. Platelets are activated by thrombin and collagen and the use of Floseal (a bovine-derived, gelatin matrix and human-derived thrombin) further potentiated the effectiveness of this strategy. With the increased incidence of intracerebral hemorrhage associated with dual antiplatelet therapy, this technique may provide a useful tool in the neurosurgical armamentarium.
双联抗血小板治疗与脑出血发生率增加相关,尤其是在蛛网膜下腔出血的情况下。我们报告一例使用Pipeline支架治疗破裂性椎动脉夹层动脉瘤的患者发生自发性出血的病例,以及术中直接应用血小板控制出血的新方法。
一名54岁既往健康的女性,出现硬膜内右侧椎动脉夹层伴一个6毫米破裂的假性动脉瘤。患者开始服用阿司匹林和氯吡格雷,并使用2个Pipeline栓塞装置重建血管。出血后第14天,她出现意识不清,右侧瞳孔散大;头颅计算机断层扫描显示右侧颞叶有一个巨大的脑内血肿。患者被紧急送往手术室清除血肿。术中,尽管静脉输注了多个单位的血小板,但仍未实现满意的出血控制。最终,将弗洛塞尔(Floseal)和血小板的混合物直接应用于血肿壁实现了迅速止血。3个月时,患者临床情况极佳,血管造影显示动脉瘤闭塞。
这是首次报道直接应用血小板实现术中止血的描述。血小板被凝血酶和胶原蛋白激活,弗洛塞尔(一种牛源性明胶基质和人源性凝血酶)的使用进一步增强了该策略的有效性。随着双联抗血小板治疗相关脑出血发生率的增加,该技术可能会成为神经外科手术器械库中的一种有用工具。